RECURSION PHARMACEUTICALS, INC. Current Assets
RECURSION PHARMACEUTICALS, INC. (RXRX) had Current Assets of $603.46 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-05
- 2026-06-30: Assets, Current $603.46M.
- 2026-03-31: Assets, Current $709.56M.
- 2025-12-31: Assets, Current $812.85M.
- 2025-09-30: Assets, Current $714.11M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $603.46M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $709.56M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $812.85M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $714.11M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $587.16M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $584.14M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $714.27M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $474.17M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $522.38M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $343.62M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $438.14M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $410.52M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $431.02M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $492.13M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $569.81M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $481.62M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $546.00M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $619.46M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $534.72M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $600.87M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $647.63M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $221.82M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $266.44M 10-K · filed 2022-03-23 | $269.48M 10-Q · filed 2021-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |